4 articles
Sun Pharmaceutical Industries agreed to acquire Organon for $11.75 billion, gaining access to its biosimilars portfolio and becoming a top-three global women's health company.
India's Sun Pharmaceutical Industries agreed to acquire U.S. drugmaker Organon & Co in an all-cash deal valued at approximately $11.75 billion. The transaction grants Sun Pharma full ownership of the
Organo has established a new subsidiary in India to target the country's growing water treatment market. This expansion supports the company's strategy to meet increasing regional demand for purificat
Organo Corp reported a decline in functional products sales for the first nine months of the fiscal year, despite rising water treatment chemical sales.
ChemBrief